Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Equity Average (2016 - 2025)

Conmed's Equity Average history spans 15 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Equity Average rose 7.69% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, up 7.69%, while the annual FY2025 figure was $997.9 million, 11.07% up from the prior year.
  • Equity Average reached $1.0 billion in Q4 2025 per CNMD's latest filing, up from $1.0 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.0 billion in Q4 2025 to a low of $694.7 million in Q3 2022.
  • Average Equity Average over 5 years is $829.5 million, with a median of $787.8 million recorded in 2022.
  • Peak YoY movement for Equity Average: dropped 7.39% in 2022, then rose 16.26% in 2024.
  • A 5-year view of Equity Average shows it stood at $770.6 million in 2021, then fell by 5.14% to $730.9 million in 2022, then increased by 11.53% to $815.2 million in 2023, then rose by 16.26% to $947.8 million in 2024, then grew by 7.69% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Equity Average are $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $990.3 million (Q2 2025).